Advertisement
Australia markets open in 8 hours 1 minute
  • ALL ORDS

    8,529.50
    +38.00 (+0.45%)
     
  • AUD/USD

    0.6727
    -0.0026 (-0.39%)
     
  • ASX 200

    8,252.80
    +38.30 (+0.47%)
     
  • OIL

    74.27
    -1.29 (-1.71%)
     
  • GOLD

    2,664.40
    -11.90 (-0.44%)
     
  • Bitcoin AUD

    98,167.70
    +5,669.77 (+6.13%)
     
  • XRP AUD

    0.81
    +0.02 (+2.63%)
     

Here's Why You Shouldn't Buy the Dip With Illumina Stock

Here's Why You Shouldn't Buy the Dip With Illumina Stock

For example, over the last five years, Illumina's (NASDAQ: ILMN) stock is down nearly 5%. For those who aren't familiar, Illumina is the undisputed king of the gene sequencer hardware market, to where many accept it as a quasi-monopoly. When healthcare systems or research laboratories need to analyze genetic material, the company's devices are the industry's standard, and it has a product in every segment of the market.